|
 Trump, who has said that pharmaceutical companies are "getting away
with murder" when it comes to charging consumers high prices for
drugs, has delayed the speech at least twice. He made the lowering
of drug prices a key issue during his 2016 presidential campaign,
but his administration and the U.S. Congress have so far failed to
deliver meaningful changes.
The administration outlined a series of proposals aimed at lowering
drug prices in its budget proposal in February, but some health
policy experts have said those policies would not significantly
alter the pricing landscape.
[to top of second column] |
It remains unclear what Trump will say in his speech or whether he
will announce concrete policies that the administration plans to
implement.
(Reporting by Yasmeen Abutaleb; Editing by Paul Simao)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
